Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brooke Swearingen, M.D.

Co-Author

This page shows the publications co-authored by Brooke Swearingen and Anne Klibanski.
Connection Strength

2.606
  1. Dopamine Agonists Can Reduce Cystic Prolactinomas. J Clin Endocrinol Metab. 2016 10; 101(10):3709-3715.
    View in: PubMed
    Score: 0.168
  2. Neuroendocrine disorders: pituitary imaging. Handb Clin Neurol. 2016; 136:873-85.
    View in: PubMed
    Score: 0.161
  3. Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary. 2013 Sep; 16(3):287-93.
    View in: PubMed
    Score: 0.137
  4. Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. Neurosurgery. 2012 Jul; 71(1):14-22.
    View in: PubMed
    Score: 0.127
  5. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol. 2011 Oct; 179(4):2120-30.
    View in: PubMed
    Score: 0.119
  6. Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf). 2010 Dec; 73(6):798-807.
    View in: PubMed
    Score: 0.113
  7. Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab. 2010 Feb; 95(2):601-10.
    View in: PubMed
    Score: 0.107
  8. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab. 2010 Feb; 95(2):567-77.
    View in: PubMed
    Score: 0.107
  9. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 2008 Oct; 93(10):4119-25.
    View in: PubMed
    Score: 0.096
  10. Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab. 2008 Jun; 93(6):2035-41.
    View in: PubMed
    Score: 0.094
  11. Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg. 2008; 55:141-4.
    View in: PubMed
    Score: 0.093
  12. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab. 2006 Nov; 91(11):4482-8.
    View in: PubMed
    Score: 0.084
  13. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006 May; 91(5):1683-90.
    View in: PubMed
    Score: 0.081
  14. Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab. 2004 Aug; 89(8):3752-63.
    View in: PubMed
    Score: 0.073
  15. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab. 2003 Oct; 88(10):4709-19.
    View in: PubMed
    Score: 0.069
  16. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab. 2002 Mar; 87(3):1262-7.
    View in: PubMed
    Score: 0.062
  17. MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands. Pituitary. 2020 Jun; 23(3):212-222.
    View in: PubMed
    Score: 0.055
  18. Activin effects on neoplastic proliferation of human pituitary tumors. J Clin Endocrinol Metab. 2000 Mar; 85(3):1009-15.
    View in: PubMed
    Score: 0.054
  19. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas. J Clin Endocrinol Metab. 1999 Dec; 84(12):4652-5.
    View in: PubMed
    Score: 0.053
  20. TWO SYNCHRONOUS PITUITARY ADENOMAS CAUSING CUSHING DISEASE AND ACROMEGALY. AACE Clin Case Rep. 2019 Sep-Oct; 5(5):e276-e281.
    View in: PubMed
    Score: 0.051
  21. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999 May 18; 130(10):821-4.
    View in: PubMed
    Score: 0.051
  22. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab. 1998 Oct; 83(10):3419-26.
    View in: PubMed
    Score: 0.049
  23. MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. Eur J Endocrinol. 2018 Sep; 179(3):191-198.
    View in: PubMed
    Score: 0.048
  24. Characterization of cyclic Cushing's disease using late night salivary cortisol testing. Clin Endocrinol (Oxf). 2018 09; 89(3):336-345.
    View in: PubMed
    Score: 0.048
  25. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab. 1998 May; 83(5):1619-23.
    View in: PubMed
    Score: 0.047
  26. Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary. 2017 Dec; 20(6):668-675.
    View in: PubMed
    Score: 0.046
  27. A decade of the Massachusetts General Hospital Neuroendocrine Clinical Center. J Clin Endocrinol Metab. 1997 Jun; 82(6):1668-74.
    View in: PubMed
    Score: 0.045
  28. Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center. Pituitary. 2016 Aug; 19(4):437-47.
    View in: PubMed
    Score: 0.042
  29. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. J Clin Endocrinol Metab. 2015 Oct; 100(10):3770-7.
    View in: PubMed
    Score: 0.039
  30. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab. 1995 Mar; 80(3):927-32.
    View in: PubMed
    Score: 0.038
  31. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. J Clin Endocrinol Metab. 1995 Jan; 80(1):147-52.
    View in: PubMed
    Score: 0.038
  32. Symptomatic salivary-rest cyst of the sella turcica. Acta Neurochir (Wien). 1995; 135(3-4):150-3.
    View in: PubMed
    Score: 0.038
  33. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol (Oxf). 2012 Sep; 77(3):430-8.
    View in: PubMed
    Score: 0.032
  34. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. J Clin Endocrinol Metab. 1991 Dec; 73(6):1248-55.
    View in: PubMed
    Score: 0.030
  35. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. J Clin Endocrinol Metab. 2009 Dec; 94(12):4851-9.
    View in: PubMed
    Score: 0.026
  36. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab. 2009 Jul; 94(7):2471-7.
    View in: PubMed
    Score: 0.025
  37. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab. 2008 Feb; 93(2):393-9.
    View in: PubMed
    Score: 0.023
  38. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract. 2007 Nov-Dec; 13(7):726-34.
    View in: PubMed
    Score: 0.023
  39. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors. J Clin Endocrinol Metab. 1999 May; 84(5):1716-21.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.